Episode Details

Back to Episodes

E133: Obinutuzumab for SLE (ALLEGORY)

Episode 134 Published 1 month, 1 week ago
Description

Good RCT this week, investigating the CD20 B cell inhibitor obinutuzumab for SLE. Sign up for my newsletter if you would like to have a read-along companion piece! 

 

Paper: https://www.nejm.org/doi/full/10.1056/NEJMoa2516150

Landing Page: https://ebrheum.com/

Substack: https://autoimmunedevreport.substack.com/

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us